Insmed (INSM) Change in Taxes (2010)

Insmed (INSM) recorded quarterly Change in Taxes of -$4.0 million in Q4 2010, down 6657.63% quarter-over-quarter from -$59000.0 in Q3 2010.

Insmed (INSM) Change in Taxes (2010) Analysis & Trends

Insmed's Change in Taxes history runs 1 years deep, the most recent figure standing at -$4.0 million for Q4 2010.

In Q4 2010, Change in Taxes changed N/A year-over-year to -$4.0 million; the TTM figure through Dec 2011 stood at -$4.0 million (changed N/A YoY), while the FY2010 annual figure was -$2.0 million, changed N/A from the prior year.
Change in Taxes was -$4.0 million for Q4 2010 at Insmed, down from -$59000.0 in the prior quarter.
In the past five years, Change in Taxes ranged from a high of -$59000.0 in Q3 2010 to a low of -$4.0 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Insmed	19.79 Bn	18.57 Bn	258.54 Mn	-

Download Data